Central Pharmaceutical Joint Stock Company No3 (HNX: DP3)
Health Care · Pharmaceuticals · VN
₫61,500.00
+2.84% today · +17.4% 1Y
Central Pharmaceutical Joint Stock Company No3 (HNX: DP3) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $50.63M.
Over the last twelve months the share price has gained 17.4%, trading between 47.00K and 67.50K.
Tweenvest scores Central Pharmaceutical Joint Stock Company No3 across four factors: quality 75/100, value 67/100, growth 92/100, dividend 91/100. Its strongest factor is growth.
DP3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.63M
- Revenue (TTM)
- $19.59M
- P/E
- 7.60
- EPS
- 8,091.45
- Dividend yield
- 6.50%
- Beta (5Y)
- 0.42
- 52-week high
- ₫67,500.00
- 52-week low
- ₫47,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.